Participant flow

Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma · Source last updated 2020-01-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Lenalidomide: 25mg once daily orally with food on days 1-21 of 28 day cycle until progression or to a maximum of 18 cycles. Dexamethasone: 10-40 mg once weekly (days 1, 8, 15, \& 22) orally with food until progression.

   id

   FG000

   title

   Lenalidomide With On-Demand Dexamethasone

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         38

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         23

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         15

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

One participant canceled prior to starting treatment; this participant has been removed from all analyses.

recruitment Details

Thirty-nine (39) participants were recruited at Mayo Clinic (Rochester) between December 2008 and April 2010.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice